Generic Selection Criteria for Safety and Patient Benefit [IV] Physicochemical and pharmaceutical properties of brand-name and generic ketoprofen tapes

被引:9
|
作者
Wada, Yuko [1 ]
Kihara, Maki [1 ]
Nozawa, Mitsuru [2 ]
Shimokawa, Ken-ichi [1 ]
Ishii, Fumiyoshi [1 ]
机构
[1] Meiji Pharmaceut Univ, Dept Pharmaceut Sci, 2-522-1 Noshio, Kiyose, Tokyo 204, Japan
[2] Triad Japan Co Ltd, Tokyo, Kanagawa, Japan
来源
DRUG DISCOVERIES AND THERAPEUTICS | 2015年 / 9卷 / 03期
关键词
Ketoprofen tape; generic; abrasion power; water-vapor permeability; pharmaceutical properties;
D O I
10.5582/ddt.2015.01032
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The physicochemical and pharmaceutical properties (pH, peel force, water-vapor permeability, and stretchability) of brand-name and generic ketoprofen products were evaluated and compared. The pHs of Mohrus as a brand-name product and Teikoku as a generic product were low (about 4). Among the other generic products, Patell and NichiIko had a pH of about 4.3 while Frestol, Raynanon, BMD, and Touchron showed a pH of 4.6-5.2, which was in the pH range of normal healthy skin (4.5-6.5). The adhesive force was high (>= 1.38) for Mohrus as a brand-name product as well as for Teikoku and Patell as generic products, but it was low (<= 0.57) for the other 5 generic products. The water-vapor permeabilities of Mohrus as a brand-name product and Teikoku and Patell as generic products were low, being less than 1/6 of those for the other 5 generic products. Among the 5 generic products, BMD showed the highest water-vapor permeability (1,330 g/m(2)), and the other products also showed a value >= 1,100 g/m(2). The elongatedness of Mohrus was the lowest (15.5 cm), and that of Raynanon was the highest (24.5 cm); the difference was 9 cm. In this study, the physiochemical and pharmaceutical properties of ketoprofen tapes were clarified, which will allow pharmacists to provide products according to the needs of each patient when a brand-name product is changed to a generic one.
引用
收藏
页码:229 / 233
页数:5
相关论文
共 41 条
  • [1] Generic selection criteria for safety and patient benefit [VIII]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic diclofenac sodium tapes
    Nozawa, Mitsuru
    Goto, Miho
    Wada, Yuko
    Yotsukura, Kayo
    Gannichida, Ako
    Ishii, Fumiyoshi
    Shimokawa, Ken-ichi
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2019, 13 (03): : 150 - 156
  • [2] Generic selection criteria for safety and patient benefit [VI]: Comparing the physicochemical and pharmaceutical properties of brand-name, generic, and OTC felbinac tapes
    Wada, Yuko
    Takaoka, Yukie
    Nozawa, Mitsuru
    Goto, Miho
    Shimokawa, Ken-ichi
    Ishii, Fumiyoshi
    [J]. Drug Discoveries and Therapeutics, 2016, 10 (06): : 300 - 306
  • [3] Generic selection criteria for safety and patient benefit [XII] : Comparing the physicochemical and pharmaceutical properties of brand-name and generic tulobuterol tape
    Shimokawa, Ken-ichi
    Yotsukura, Kayo
    Nozawa, Mitsuru
    Wada, Yuko
    Ishii, Fumiyoshi
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2023,
  • [4] Generic selection criteria for safety and patient benefit [VII]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic terbinafine hydrochloride cream
    Nozawa, Mitsuru
    Goto, Miho
    Wada, Yuko
    Kumazawa, Miyuki
    Shimokawa, Ken-ichi
    Ishii, Fumiyoshi
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2018, 12 (01): : 16 - 20
  • [5] Generic selection criteria for safety and patient benefit [X]: Water-vapor permeability and peel force properties of brand-name and generic ketoprofen tapes
    Nozawa, Mitsuru
    Goto, Miho
    Wada, Yuko
    Ishii, Fumiyoshi
    Shimokawa, Ken-ichi
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2021, 15 (02): : 87 - 92
  • [6] A questionnaire survey of patients comparing the usability of brand-name and generic ketoprofen tapes
    Saita, Asunti
    Inoue, Ayako
    Ishibashi, Hisashi
    Tominaga, Koji
    Hori, Satoko
    Miki, Akiko
    Ohtani, Hisakazu
    Ono, Nobuaki
    Sawada, Yasufumi
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2008, 128 (05): : 795 - 803
  • [7] Generic selection criteria for safety and patient benefit [XI]: Usability scores of brand- name and generic tapes containing sodium diclofenac by questionnaire survey
    Nozawa, Mitsuru
    Gannichida, Ako
    Wada, Yuko
    Kumazawa, Miyuki
    Ishii, Fumiyoshi
    Shimokawa, Ken-ichi
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2022, 16 (05): : 210 - 216
  • [8] GENERIC AND ALTERNATIVE BRAND-NAME PHARMACEUTICAL EQUIVALENTS - SELECT WITH CAUTION
    HENDELES, L
    HOCHHAUS, G
    KAZEROUNIAN, S
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (02): : 323 - 329
  • [9] Comparison of the Properties of Brand-Name and Generic Nadifloxacin Creams
    Inoue, Yutaka
    Matsumoto, Miruto
    Kimura, Masayuki
    Tanaka, Toru
    Kanamoto, Ikuo
    [J]. MEDICINA-LITHUANIA, 2011, 47 (11): : 616 - 622
  • [10] Safety of Overnight Switch from Brand-Name to Generic Levetiracetam
    Vari, Maria Stella
    Pinto, Francesca
    Mencaroni, Elisabetta
    Giudizioso, Giovanna
    Minetti, Carlo
    La Neve, Angela
    Francavilla, Tiziana
    Piccioli, Marta
    Striano, Salvatore
    del Gaudio, Luigi
    Tovo, Pierangelo
    Striano, Pasquale
    Verrotti, Alberto
    [J]. CLINICAL DRUG INVESTIGATION, 2016, 36 (01) : 87 - 91